Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

[Treatment with venlafaxine extended release for climacteric women with depression or anxiety diagnosis. An open-label study].

Iglesias C, Pato E, Ocio S, Ortigosa JC, Santamarina S, Merino MJ, Alonso MJ, Fernández L, Alonso JL, Rodríguez L.

Actas Esp Psiquiatr. 2009 May-Jun;37(3):137-42. Spanish.

2.
3.

Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.

Davidson JR, DuPont RL, Hedges D, Haskins JT.

J Clin Psychiatry. 1999 Aug;60(8):528-35.

PMID:
10485635
4.

Venlafaxine extended-release in patients older than 80 years with depressive syndrome.

Baca E, Roca M, Garcia-Calvo C, Prieto R.

Int J Geriatr Psychiatry. 2006 Apr;21(4):337-43.

PMID:
16570327
5.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
6.
7.

Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.

Ladd CO, Newport DJ, Ragan KA, Loughhead A, Stowe ZN.

Depress Anxiety. 2005;22(2):94-7.

PMID:
16094663
8.

[Response and remission in depressive patients with anxiety symptoms treated with venlafaxine extended release in primary care].

Roca Benassar M, Baca Baldomero E.

Actas Esp Psiquiatr. 2006 May-Jun;34(3):162-8. Spanish.

PMID:
16736389
10.

A meta-analysis of the effects of venlafaxine on anxiety associated with depression.

Rudolph RL, Entsuah R, Chitra R.

J Clin Psychopharmacol. 1998 Apr;18(2):136-44.

PMID:
9555599
12.
13.

[Gender differences in clinical profile, response and remission of depressive patients treated with venlafaxine extended release].

Roca M, Baca E, Prieto R, García-Calvo C.

Actas Esp Psiquiatr. 2008 Mar-Apr;36(2):82-9. Spanish.

14.

A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients.

Diaz-Martinez A, Benassinni O, Ontiveros A, Gonzalez S, Salin R, Basquedano G, Martinez RA.

Clin Ther. 1998 May-Jun;20(3):467-76.

PMID:
9663362
15.

Depression in primary care: effectiveness of venlafaxine extended-release in elderly patients; Observational study.

Cervera-Enguix S, Baca-Baldomero E, Garcia-Calvo C, Prieto-López R; TESEO Study Group.

Arch Gerontol Geriatr. 2004 May-Jun;38(3):271-80.

PMID:
15066313
17.

Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.

Liebowitz MR, Gelenberg AJ, Munjack D.

Arch Gen Psychiatry. 2005 Feb;62(2):190-8.

PMID:
15699296
18.

Effectiveness and safety of venlafaxine extended release in elderly depressed patients.

Ibor JJ, Carrasco JL, Prieto R, García-Calvo C; Ceres Study Group.

Arch Gerontol Geriatr. 2008 May-Jun;46(3):317-26. Epub 2007 Jul 6.

PMID:
17617478
19.

[The current challenges of the treatment of depression: venlafaxina extended release and remission outcomes in real-world clinical practice].

Ros Montalbán S, Mora Ripoll R, Garcia-Garcia M; Grupo del Estudio DAFNE.

Actas Esp Psiquiatr. 2005 May-Jun;33(3):165-72. Spanish.

PMID:
15918084
20.

Venlafaxine extended release in the short-term treatment of depressed and anxious primary care patients with multisomatoform disorder.

Kroenke K, Messina N 3rd, Benattia I, Graepel J, Musgnung J.

J Clin Psychiatry. 2006 Jan;67(1):72-80.

PMID:
16426091

Supplemental Content

Support Center